Summary Safety Review - Atypical antipsychotics - Assessing the potential risk of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
Data and Resources
Additional Info
| Field | Value |
|---|---|
| Last Updated | April 17, 2026, 22:00 (UTC) |
| Created | April 17, 2026, 22:00 (UTC) |
| criticality_level | [] |
| geographic_scope | [] |
| open_canada_collection | publication |
| open_canada_date_published | 2020-12-04 00:00:00 |
| open_canada_keywords | {"fr": ["Résumé de l'examen de l'innocuité", "antipsychotiques atypiques", "évaluation", "risque potentiel", "réaction médicamenteuse avec éosinophilie et symptômes systémiques", "DRESS", "informations sur la sécurité du produit", "Zyprexa (olanzapine)", "Zeldox (ziprasidone)", "effets secondaires potentiellement mortels", "effets secondaires -effet des médicaments", "fièvre", "éruption cutanée sévère", "visage enflé", "desquamation de la peau"], "en": ["Summary Safety Review", "Atypical antipsychotics", "assessing", "potential risk", "Drug-Reaction-with-Eosinophilia-and-Systemic-Symptoms", "DRESS", "product safety information", "Zyprexa (olanzapine)", "Zeldox (ziprasidone)", "life-threatening side-effects", "side-effect to medications", "fever", "severe skin rash", "swollen face", "peeling of the skin"]} |
| open_canada_subject | ["health_and_safety"] |
| sensitivity_level | unrestricted |
| title_fr | Résumé de l’examen de l’innocuité - Antipsychotiques atypiques - Évaluation du risque de syndrome d’hypersensibilité médicamenteuse avec éosinophilie et symptômes généraux (syndrome DRESS) |
| update_frequency | as_needed |